(Q34608780)

3 August 2017

title

Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy (English)

1 reference

3 August 2017

author name string

Tricia Stewart Foster

series ordinal

1

1 reference

3 August 2017

publication date

1 January 2007

1 reference

The Science of Diabetes Self-Management and Care

3 August 2017

published in

1 reference

3 August 2017

volume

33

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

111-117

1 reference

3 August 2017

cites work

Diabetic neuropathies

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Practical management of patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Glycemic control is related to the morphological severity of diabetic sensorimotor polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Alpha-lipoic acid as a biological antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

The pharmacology of the antioxidant lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0145721706297450

21 January 2018

Identifiers

DOI

10.1177/0145721706297450

1 reference

3 August 2017

1 reference